This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: The Innovative Contributions of Desta Doro Bume
Introduction
Desta Doro Bume is a notable inventor based in Broomfield, Colorado. She has made significant contributions to the field of medical research, particularly in the development of compounds aimed at treating various serious health conditions. With a total of 5 patents to her name, her work is paving the way for advancements in therapeutic treatments.
Latest Patents
Desta's latest patents focus on FGFR3 inhibitor compounds. These compounds are designed for use in the treatment of systemic sclerosis, fibrosis (including pulmonary fibrosis), achondroplasia, thanatophoric dysplasia (type I), severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), muenke syndrome, and cancer. The innovative nature of these compounds highlights her commitment to addressing complex medical challenges.
Career Highlights
Desta is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its dedication to improving patient outcomes through innovative solutions. Her role at the company allows her to collaborate with other talented professionals in the field, further enhancing her contributions to medical science.
Collaborations
Some of Desta's coworkers include Adedoyin David Abraham and Kevin Ronald Condroski. Their collaborative efforts contribute to the dynamic environment at Eli Lilly and Company, fostering innovation and research excellence.
Conclusion
Desta Doro Bume's work exemplifies the impact of innovation in the medical field. Her patents and collaborations reflect a commitment to advancing healthcare solutions. Through her efforts, she is making a significant difference in the lives of patients facing serious health challenges.